These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19750119)

  • 21. Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion.
    Scott BR; Uomoto JM; Barry ES
    Headache; 2020 Mar; 60(3):526-541. PubMed ID: 31898813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The point prevalence of dizziness or vertigo in migraine--and factors that influence presentation.
    Calhoun AH; Ford S; Pruitt AP; Fisher KG
    Headache; 2011 Oct; 51(9):1388-92. PubMed ID: 21797862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management training.
    Holroyd KA; Cordingley GE; Pingel JD; Jerome A; Theofanous AG; Jackson DK; Leard L
    Headache; 1989 Mar; 29(3):148-53. PubMed ID: 2496052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose propofol for the abortive treatment of pediatric migraine in the emergency department.
    Sheridan DC; Spiro DM; Nguyen T; Koch TK; Meckler GD
    Pediatr Emerg Care; 2012 Dec; 28(12):1293-6. PubMed ID: 23187986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric migraine: abortive management in the emergency department.
    Sheridan DC; Spiro DM; Meckler GD
    Headache; 2014 Feb; 54(2):235-45. PubMed ID: 24512575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ziprasidone as a Potential Abortive Therapy for Status Migrainosus.
    Landsness EC; Wang LH; Bucelli RC
    Neurohospitalist; 2016 Oct; 6(4):151-156. PubMed ID: 27695596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migraine Headache: Immunosuppressant Therapy.
    Rozen TD
    Curr Treat Options Neurol; 2002 Sep; 4(5):395-401. PubMed ID: 12162928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Critical Evaluation on MOH Current Treatments.
    Negro A; Curto M; Lionetto L; Guerzoni S; Pini LA; Martelletti P
    Curr Treat Options Neurol; 2017 Aug; 19(9):32. PubMed ID: 28808924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sinus headache, migraine, and the otolaryngologist.
    Mehle ME; Schreiber CP
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):489-96. PubMed ID: 16213917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosing and managing migraine headache.
    Mueller LL
    J Am Osteopath Assoc; 2007 Nov; 107(10 Suppl 6):ES10-6. PubMed ID: 17986672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
    Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
    Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Headache: Migraine.
    Mayans L
    FP Essent; 2018 Oct; 473():11-16. PubMed ID: 30346679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic migraine.
    Schwedt TJ
    BMJ; 2014 Mar; 348():g1416. PubMed ID: 24662044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey on treatments for primary headaches in 13 specialized juvenile Headache Centers: The first multicenter Italian study.
    Toldo I; Rattin M; Perissinotto E; De Carlo D; Bolzonella B; Nosadini M; Rossi LN; Vecchio A; Simonati A; Carotenuto M; Scalas C; Sciruicchio V; Raieli V; Mazzotta G; Tozzi E; Valeriani M; Cianchetti C; Balottin U; Guidetti V; Sartori S; Battistella PA
    Eur J Paediatr Neurol; 2017 May; 21(3):507-521. PubMed ID: 28082014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
    Edwards KR; Norton J; Behnke M
    Headache; 2001; 41(10):976-80. PubMed ID: 11903525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Characteristics and Management of Headache: A Real-Life Prospective, Observational Study From a Tertiary Care Center in Eastern India.
    Nayak S; Parida M; Das SB; Padhi PK; Behera M; Patil A; Khurana A; Kumar Swain S
    Cureus; 2020 Dec; 12(12):e12409. PubMed ID: 33409110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study.
    Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC
    Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):41-7. PubMed ID: 14971122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic headaches in family practice.
    Smith R
    J Am Board Fam Pract; 1992; 5(6):589-99. PubMed ID: 1462793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.